SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frank Buck who wrote (679)12/15/1997 9:17:00 AM
From: Cisco  Read Replies (1) of 1894
 
Frank,

With so many analysts not giving a estimate ESP for this quarter, I wonder what the street number is that AccuMed needs to beat? I am assuming they will use First Call's -0.07. What do you think?

With this being the 4th quarter, I assuming that the final numbers will not be released until at least mid February. With the new emphasis on Public Relations, do you think AccuMed might issue a statement in January on whether they expect to beat the street numbers?

I also find it interesting that the analysts that are closest to AccuMed are silent on 4th quarter earnings. (ie. Commonwealth Associates & Vector Securities). Both have recently reiterated their strong buy recommendations. Makes one wonder if we should expect a positive earning surprise? With Robert L. Priddy and Michael S. Faulk connection to AccuMed you would think that at least Commonwealth Associates would have a good idea what earnings will be.

Cisco
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News